• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Primary mediastinal large B-cell lymphoma in paediatric and adolescent patients: emerging questions in the era of immunotherapy.

作者信息

Kohorst Mira A, Nunez Cesar A, Tewari Priti, Petropoulos Demetrios, Mahadeo Kris M, Neelapu Sattva S, Shpall Elizabeth J, Khazal Sajad

机构信息

Division of Pediatrics, Pediatric Stem Cell Transplantation and Cellular Therapy, CARTOX Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Br J Haematol. 2020 Jul;190(2):e114-e117. doi: 10.1111/bjh.16761. Epub 2020 May 29.

DOI:10.1111/bjh.16761
PMID:32469086
Abstract
摘要

相似文献

1
Primary mediastinal large B-cell lymphoma in paediatric and adolescent patients: emerging questions in the era of immunotherapy.儿童和青少年原发性纵隔大B细胞淋巴瘤：免疫治疗时代出现的新问题
Br J Haematol. 2020 Jul;190(2):e114-e117. doi: 10.1111/bjh.16761. Epub 2020 May 29.
2
A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.一项评估抗 CD19 抗体药物偶联物 coltuximab ravtansine（SAR3419）在既往接受基于利妥昔单抗免疫治疗的复发或难治性弥漫性大 B 细胞淋巴瘤患者中的疗效和安全性的多中心 II 期研究。
Haematologica. 2018 Aug;103(8):1351-1358. doi: 10.3324/haematol.2017.168401. Epub 2018 May 10.
3
The unique biology and treatment of primary mediastinal B-cell lymphoma.原发性纵隔B细胞淋巴瘤的独特生物学特性与治疗方法
Best Pract Res Clin Haematol. 2018 Sep;31(3):241-250. doi: 10.1016/j.beha.2018.07.001. Epub 2018 Jul 3.
4
Treatment of Richter transformation-immunotherapy to the rescue?里氏转化的治疗——免疫疗法来拯救？
Lancet Oncol. 2024 Oct;25(10):1248-1249. doi: 10.1016/S1470-2045(24)00485-6. Epub 2024 Sep 10.
5
Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab.
Int J Hematol. 2020 Oct;112(4):597-598. doi: 10.1007/s12185-020-02989-5. Epub 2020 Sep 4.
6
Immunotherapy: CAR T cells ready to go mainstream.
Nat Rev Clin Oncol. 2016 Jul;13(7):396-7. doi: 10.1038/nrclinonc.2016.99. Epub 2016 Jun 14.
7
Mechanism and Treatment of Rituximab Resistance in Diffuse Large Bcell Lymphoma.弥漫大 B 细胞淋巴瘤中利妥昔单抗耐药的机制与治疗。
Curr Cancer Drug Targets. 2019;19(9):681-687. doi: 10.2174/1568009619666190126125251.
8
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.高剂量化疗用于复发难治性弥漫性大B细胞淋巴瘤：纵隔定位预示良好预后。
J Clin Oncol. 1998 Jan;16(1):63-9. doi: 10.1200/JCO.1998.16.1.63.
9
CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.CD40 通路激活状态可预测弥漫性大 B 细胞淋巴瘤对 CD40 治疗的反应。
Sci Transl Med. 2011 Mar 16;3(74):74ra22. doi: 10.1126/scitranslmed.3001620.
10
Rituximab and reduced-intensity chemotherapy in children and adolescents with mature B-cell lymphoma: interim results for 231 patients enrolled in the second Russian-Belorussian multicentre study B-NHL-2010M.利妥昔单抗联合低强度化疗治疗儿童和青少年成熟 B 细胞淋巴瘤：231 例患者的二次俄罗斯-白俄罗斯多中心研究 B-NHL-2010M 的中期结果。
Br J Haematol. 2019 Aug;186(3):477-483. doi: 10.1111/bjh.15944. Epub 2019 May 9.

引用本文的文献

1
Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B-cell lymphoma in an adolescent patient.利妥昔单抗治疗一名青少年复发性难治性原发性纵隔大B细胞淋巴瘤患者
EJHaem. 2024 Feb 12;5(1):153-156. doi: 10.1002/jha2.859. eCollection 2024 Feb.
2
Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective.儿童、青少年及青年人群侵袭性非霍奇金淋巴瘤的管理：成人视角与儿童视角对比
Cancers (Basel). 2022 Jun 13;14(12):2912. doi: 10.3390/cancers14122912.
3
Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
博纳吐单抗与单倍体相合供者白细胞输注联合应用于难治性原发性纵隔大B细胞淋巴瘤
Ther Adv Hematol. 2021 Feb 23;12:2040620721994348. doi: 10.1177/2040620721994348. eCollection 2021.